The involvement of genetic factors in the etiology of autism has been clearly established. We undertook a genome-wide search for regions containing susceptibility genes for autism in 12 subjects with childhood autism and related pervasive developmental disorders (PDDs) and 44 controls from the relatively isolated population of the Faroe Islands. In total, 601 microsatellite markers distributed throughout the human genome with an average distance of 5.80 cM were genotyped, including 502 markers in the initial scan. The Faroese population structure and genetic relatedness of cases and controls were also evaluated. Based on a combined approach, including an assumption-free test as implemented in CLUMP, Fisher's exact test for specific alleles and haplotypes, and IBD 0 probability calculations, we found association between autism and microsatellite markers in regions on 2q, 3p, 6q, 15q, 16p, and 18q. The most significant finding was on 3p25.3 (P T1 ¼ 0.00003 and P T4 ¼ 0.00007), which was also supported by other genetic studies. Furthermore, no evidence of population substructure was found, and a higher degree of relatedness among cases could not be detected, decreasing the risk of inflated P-values. Our data suggest that markers in these regions are in linkage disequilibrium with genes involved in the etiology of autism, and we hypothesize susceptibility genes for autism and related PDDs to be localized within these regions.
Introduction
Childhood autism is a pervasive neurodevelopmental disorder with onset of symptoms before the age of 3 years. The symptoms include severe impairments of communicative and social skills, together with stereotyped and repetitive behavior. 1 Related disorders falling short of strict diagnostic criteria for childhood autism comprise Asperger's syndrome, atypical autism, and pervasive developmental disorder. Based on family and twin studies there is strong evidence of a genetic component. 2, 3 The mode of inheritance is unknown, but a polygenic model has been suggested with estimates of the number of genes involved, ranging from three to more than 15 genes. 4, 5 Based on genome-wide scans, screening of possible candidate genes, and studies of association between autism and chromosome abnormalities, candidate regions of autism have been suggested on chromosome 2q, [6] [7] [8] 7q, 9, 10 and 15q. 11, 12 However, no susceptibility genes have yet been identified, and except for a few specific etiological factors like the fragile X syndrome, tuberous sclerosis, and maternally inherited duplication of 15q11-13, the etiology of autism is largely unknown. 13 The use of isolated populations is a powerful approach in the search for disease genes and has facilitated the identification of candidate chromosome regions involved in monogenic diseases 14 and in some complex diseases, for example, uric acid nephrolithiasis. 15 Isolated populations have also been used to study susceptibility genes for autism-spectrum disorders in Finland, and evidence for a susceptibility locus was found on chromosome 3q25-27, 16 in addition to evidence for risk loci for Asperger's syndrome on 1q21-22, 3p14-24, and 13q31-33. 17 We used the isolated population of the Faroe Islands to search for susceptibility genes of autism. The Faroe Islands are situated in the North Atlantic Ocean between Norway, Scotland, and Iceland. Based on historical records the establishment of the population was presumably caused by emigration mainly from Bergen and the surrounding area in Norway approximately 900 AD, but people from the British Isles may also have contributed to the colonization of the islands. 18 Based on a genetic study of paternally inherited Y-chromosomes from the Faroese population, it is likely that the Faroe Islands were colonized by males from Norway, Sweden, and Scotland. 18 The population has expanded from a few thousand people to the present level of approximately 45 000 inhabitants, covering periods of constant population size as well as putative periods of population bottlenecks with less than 4000 inhabitants due to severe epidemics. 19 Migration has been sparse, 18 and presumably the expansion has mainly been due to increased reproduction rates. The long distances between the villages, commercial monopoly, and legislation, imposed further isolation between different geographical areas on the Faroe Islands. 19 Increased occurrence of diseases caused by specific gene mutations, like cystic fibrosis and glycogen storage disease IIIA, has been reported on the Faroe Islands, 20, 21 and a locus for primary ciliary dyskinesia has been identified in Faroese families. 22 The Faroese population has, in addition, been used to localize interesting chromosome regions for bipolar affective disorder and schizophrenia. 23, 24 These findings indicate that the population on the Faroe Islands may be suitable for identification of gene mutations. Fewer, but more frequent risk loci and alleles presumably exist at the population level, compared to an outbred population, due to the action of random genetic drift caused by a founder event followed by putative bottlenecks in the size of the Faroese population. Furthermore, this recent founding, isolation, and relatively rapid expansion of the Faroese population is reflected in the extensive background linkage disequilibrium (LD) observed in the population. 25 In the present study, distantly related individuals with childhood autism and related pervasive developmental disorders (PDDs) from the Faroe Islands were genotyped for polymorphic markers distributed throughout the human genome in the search for allele and haplotype association. Association between specific markers and the disorder suggests that the markers are in LD with, and therefore presumably lie close to a susceptibility gene, and may thus contribute to the localization of candidate regions for autism.
Materials and methods

Sample
Individuals with autism and related disorders were recruited through the National Society for Autism on the Faroe Islands without prior knowledge of the genealogical relationship between cases. Diagnostic assessment was performed by one of the authors (MB Lauritsen), using the Autism Diagnostic Observation Schedule Generic (ADOS-G) 26 and the Autism Diagnostic Interview-Revised (ADI-R). 27 The observation (ADOS-G) was videotaped, and the interview (ADI-R) was recorded on audio-tape. ADOS-G and ADI-R are based on the International Classification of Diseases, 10th edition (ICD-10) 1 and the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). 28 The final diagnosis based on ADI-R and ADOS-G was made in collaboration with an independent expert, Lennart Pedersen, National Centre for Autism, Copenhagen, Denmark. Tests of the cognitive level of cases were not performed.
In total, 12 individuals were included in the study. All cases were males, and the mean age of the probands at the time of assessment was 17 years (age range, 4-41 years). Controls were randomly ascertained and consisted of 22 pairs of parents (44 presumably unrelated adults). Controls were without a history of psychiatric disorders at the time of inclusion in the study.
The diagnoses of the 12 cases are indicated in the genealogy shown in Figure 1 . Seven cases fulfilled the criteria for childhood autism, whereas one case fulfilled the criteria for atypical autism because the specific impairments in areas of social interaction, communication, and behavior were not present before the age of 3 years. Another case fulfilled the criteria for Asperger's syndrome, and three autistic cases were severely mentally retarded. Three diagnostic categories were used to define the relevant phenotype of autism. The core category includes the seven cases diagnosed with childhood autism, whereas the narrow category also includes the two cases diagnosed with Asperger's syndrome and atypical autism. The broad category comprises all 12 cases including the three severely mentally retarded subjects whose cognitive level makes a diagnosis of autism uncertain, using the diagnostic instruments.
Genotyping DNA was prepared from whole blood using a standard sucrose/Triton-lysis protocol with sodium chloride/ isopropanol precipitation. DNA amplification was performed either as single or multiplex PCR with a maximum of three markers simultaneously. DNA fragments were subsequently analyzed on an ABI Prism 310 Genetic Analyzer or an ABI Prism 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA).
Haplotypes for chromosomal segments consisting of two and three neighboring markers were determined for cases based on parental genotypes and for controls based on the genotypes of one of their offspring assuming that no recombination occurred in this generation. This is only valid when markers are in relatively close proximity because the chance of meiotic crossover from parent to offspring increases with increasing distance between markers. This method will reconstruct the majority of relatively short haplotypes correctly. 23, 29 The present scan was performed in two stages. First, a genome-wide scan was made, using 502 randomly chosen and more or less evenly distributed markers (average distance 6.97 cM, range 0-16.27 cM) and a P-value of 0.01 as threshold for interesting regions. In the second scan 30 additional microsatellites were genotyped and tested around the original 14 interesting markers. As the present scan is part of a larger study, also containing samples of bipolar affective disorder and schizophrenia, additional markers located around interesting markers for these two disorders were also included in the second scan in order to increase the marker density. Specific additional markers were chosen based on the level of heterozygosity in the CEPH database (http:// www.cephb.fr/cgi-bin/wdb/ceph/systeme/form) in addition to having a position 1-2 cM distal and proximal to interesting original markers. In total, 601 microsatellite markers with an average distance of 5.80 cM (range 0-16.27 cM) were used to cover the whole genome. The order of the microsatellites was based on the public available database (http://genome.cse.ucsc.edu), and linkage map distances, in Kosambi centimorgans, were obtained from the Marshfield Center for Medical Genetics (http://research.marshfieldclinic.org).
The Faroese population
On the Faroe Islands church records have been kept since 1727 or 1750 depending on the region, whereas incomplete church records and civic records have been kept for even longer. Using church and civic records of births, marriages, and deaths, the genealogical relationship between cases was investigated, whereas the genealogical information for controls is currently unavailable. The average pairwise number of generations relating two patients to a common ancestor in the genealogically shortest possible way through one of their parents was estimated (see Figure  1) , and pairs of the 12 individuals with childhood autism and related PDDs were on average related to a common ancestor 7.2 generations back in time. This is assumed to ensure a reasonable size of the shared chromosomal region surrounding a putative susceptibility gene.
When using a case-control design in association studies, it is essential that cases and controls are subsamples of the same larger population and share the same genetic history. While the sample of controls is essentially randomly chosen with respect to LD, a sample of affected individuals in a population isolate is, by definition, chosen to be enriched for LD in the region of disease-related variants, and therefore also tends to share alleles of surrounding markers. In such a scenario cases tend to be more related in general than the sample of controls, causing an increased false-positive error rate and inflated P-values. Instead of detecting true association between a marker and a trait, classical case-control analysis might therefore detect differences between cases and controls owing to ignored population substructure or improperly accounted relatedness among individuals. 30, 31 In order to evaluate whether the population on the Faroe Islands is suitable for identifying candidate genes of autism, we investigated population substructure and the degree of relatedness among individuals.
Estimates of genetic relatedness (r) were calculated using the algorithms developed by Queller and Goodnight 32 based on 60 randomly selected unlinked markers as implemented in SPAGEDi 1.2. 33 Markers were chosen at an intermarker distance of 50 cM or more. Pairwise estimates of r can be interpreted as a measure of similarity between individuals, and it is used to investigate whether cases were genetically more similar than controls. Estimates of pairwise genetic distances between individuals were obtained using the algorithm developed by Rousset 34 as implemented in SPAGEDi 1.2. Pairwise genetic distances were used in a multidimensional scaling algorithm (Alscal procedure -as implemented in
Asperger's syndrome
Atypical autism
Mental retardation Figure 1 The genealogy of cases. Individual diagnoses are indicated by different shadings of cases. Owing to severe mental retardation in three of the cases, a diagnosis of autism using ADI and ADOS was difficult to apply.
SPSS 11.5) to map similarity between individuals relative to each other, that is, to inspect potential clustering of cases relative to controls. The population structure, including the genetic differentiation within the case-control sample, was evaluated by Wright's F-statistics and Bayesian model-based clustering using multilocus genotype data. The 60 unlinked markers were used to calculate the genetic distance between the case and control group using Wright's F ST . This measure is based on a hierarchical analysis, where the total variance is partitioned into covariance components due to differences in allele frequencies between populations, between individuals in populations, and between alleles in individuals. 35 Under the hypothesis of no differentiation between the individuals and populations, a null distribution of F IT , F IS , and F ST values was obtained performing 3000 permutations of individual genotypes among all individuals (F IT ), among individuals within populations (F IS ), and among populations (F ST ) as implemented in SPAGEDi 1.2.
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In addition, Bayesian model-based clustering using multilocus genotype data, as implemented in STRUC-TURE 2.1, 36 was applied in order to infer any potential cryptic population substructure in the data set. An admixture linkage model was applied without using any prior information on population structure. In addition to taking into account that individuals may have mixed ancestry, and that different parts of their genome may actually belong to different clusters of the data set, the admixture linkage model also considers the possibility of correlations between markers due to linkage ('admixture linkage disequilibrium'). 37 This method does not attempt to model the LD that occurs within populations between very close markers, and markers on the autosomes were excluded in such a way that all intermarker distances were above 1 cM, leaving a total of 529 markers in the data set. In the analyses partial phase information was used. A burning length of 100 000 simulations, followed by 1 000 000 simulations was used to get accurate parameter estimates. Five iterations were performed for each of the following number of putative clusters/subpopulations KA [1;3] . STRUC-TURE thus identifies clusters of related individuals within the sample from multilocus genotypes, and should also be able to indicate whether cases are indeed more related to each other than to controls. The analyses supplement the estimates of average relatedness and pairwise individual genetic distances in suggesting whether cases and controls fall into the same genealogy or not.
The case-control study Test for association between autism and related PDDs and any of the markers was performed using Monte Carlo based tests as implemented in the computer program CLUMP 38 (http://www.mds.qmw.ac.uk/statgen/dcurtis). CLUMP is particularly useful for highly polymorphic markers, especially when the sample size is small because only few observations may then be seen for some of the alleles or haplotypes. Allele and haplotype frequencies among cases and controls were compared, either as single markers or as two-or three-marker segments. CLUMP generates four test statistics. We chose to report the empirical P-value from the T1 and T4 test statistics as these tests are more powerful for evaluating association than the other two test statistics.
38 T1 is a w 2 test of the raw 2 Â N table that evaluates the significance of association with alleles/haplotypes. For T4 the columns of the raw 2 Â N table are clumped together in a new 2 Â 2 table, and each allele/haplotype is reshuffled subsequently in order to maximize the w 2 value. T4 evaluates the situation where more than one rare allele/haplotype is responsible for the deviation. For both tests, we performed 100 000 simulations in order to generate a null distribution of the test statistics and evaluate empirical significance.
Subsequently, for markers or segments yielding low P-values (Pp0.01), alleles or haplotypes with a high frequency among cases compared to controls were evaluated using Fisher's two-tailed exact test. Fisher's exact test is applied when very few observations are seen in each cell of a contingency table as is the case in our study. It is used to evaluate the significance of the differences in frequency of the specific allele or haplotype between cases and controls.
Relatives share, on average, relatively large chromosomal segments. Distantly related affected individuals may, therefore, share haplotypes that are identical by descent by chance (IBD 0 ) from a common ancestor without necessarily containing a shared disease gene. If affected individuals are more closely related than the controls in a case-control design, this may result in inflated P-values. In order to determine whether a potential association between autism and related PDDs and single-or two-marker segments is due to IBD 0 , the probability that affected individuals share a haplotype that is IBD 0 from a known ancestor through a specific genealogical relationship was calculated using the formulas derived by Houwen et al. 39 and Durham & Feingold. 40 In these formulas, the average pairwise relationship with a common ancestor of the 12 individuals with autism and related PDDs were used. P 0 is the probability of the observed number of cases having the most frequent haplotype IBD 0 from a known ancestor (i.e. false positive probability) according to Houwen et al.
39 P 1 is the same probability summed over all segments typed on the chromosome. P 2 is the genome wide probability of IBD 0 according to the method by Durham & Feingold. 40 This was done for segments with a low CLUMP P-value (Pp0.01) for haplotypes with a higher frequency among cases compared to controls.
Results
In the initial CLUMP analyses using 502 markers and the broader category of cases, nine chromosomal regions (3p, 4q, 6q, 10p, 10q, 14q, 15q, 17q , and Xq) showed interesting findings (Pp0.01). When additional markers were added in the follow-up analyses, diminished evidence of association was found in two regions (4q and Xq) whereas evidence of association was either maintained or increased in the remaining regions. In addition, interesting regions also appeared on 2q, 5q, 8p, 11p, 12q, 16p, 18q, and 19q in the follow-up analyses (Table 1) . Only analyses of single-and two-marker segments are shown in Table 1 because only very few interesting threemarker segments were found, and they are mentioned in the text.
When comparing the distribution of alleles or haplotypes between cases and controls in these interesting regions using Fisher's exact test and the same level of significance, seven chromosome regions (3p, 5q, 6q, 12q, 14q, 15q, and 18q) appeared to have markers or segments with significant deviation in frequency of a single allele or haplotype. In all cases except on chromosome 6q, the P-values of Fisher's exact test were lower than the P-values obtained by CLUMP.
The largest deviation in frequency of a single allele among cases and controls was found on chromosome 12q for the 239-allele of marker D12S395 (Table 1) . For marker D5S1501 on chromosome 5q and for marker D3S3594 on chromosome 3p we found a large, statistically significant, deviation in frequency of allele 98 and allele 271, respectively, among cases and controls. Furthermore, a haplotype (271-2) of the two-marker segments D3S3594-D3S3589 at 32.36 cM was close to significantly more frequent among cases than controls, and the probability (P 0 and P 1 ) that six out of 22 haplotypes are shared IBD 0 in cases related 7.2 generations ago is as small as 2.7 Â 10 À8 and 1.7 Â 10
À7
, respectively, according to the formula of Houwen 39 and P 2 ¼ 3.7 Â 10 À5 according to Durham and Feingold. 40 The frequency of allele 206 of marker D15S198 on chromosome 15q also appeared to be significantly different among cases compared to controls. A single haplotype (206-7) of the twomarker segment D15S198-D15S643, spanning 51.21-52.33 cM, proved to have significantly higher frequency among cases compared to controls, and IBD 0 calculations showed that IBD 0 is less likely. Haplotype 162-360 of D18S536-D18S970 on chromosome 18 occurred on six out of 23 case chromosomes and on two out of 73 control chromosomes, and calculation of IBD 0 probabilities suggests that IBD 0 is less likely considering the specified genealogy. At marker D14S53 on chromosome 14q and at chromosome 6q at marker D6S1652 a single allele was significantly more prevalent in case chromosomes than in control chromosomes.
One three-marker segment spanning 172.27-181.87 cM on chromosome 3 (D3S2404-D3S1763-D3S3053) appeared to be associated with autism and related disorders (CLUMP P T1 ¼ 0.0065 and P T4 ¼ 0.0223). Furthermore, a single haplotype (1-272-238) of this three-marker segment proved to have significantly higher frequency among cases compared to controls (P ¼ 0.0014), and calculation of IBD 0 probabilities suggests that IBD 0 by chance is less
, and P 2 ¼ 0.051) considering the specified genealogy.
The association analyses as implemented in CLUMP, using all 601 genetic markers, were also performed for a subsample of seven cases with a diagnosis of childhood autism and in a subsample excluding the three severely mentally retarded cases. However, the results only differed slightly from the results of the total sample including 12 cases.
Average 34 between individuals did not reveal any overall clustering of cases in relation to controls (results not shown).
Running STRUCTURE for different numbers of assumed K clusters indicated that a single cluster (K ¼ 1) was more likely compared to multiple clusters (K ¼ 2,3) given the current data set ( Table 2 ). Applying a model without admixture gave similar results (results not shown). Most individuals had the majority of their genome assigned to the same single cluster, except for two controls who had the majority of their genome assigned to another cluster. These two individuals also appeared to have a high pairwise relatedness and a short genetic distance (results not shown). Therefore, the presence of any cryptic population substructure could not be clearly demonstrated.
In accordance with this, the amount of genetic differentiation (F ST ) between cases and controls was not statistically significant, when using the method implemented in SPAGEDi 1.2 using 60 unlinked markers (F ST ¼ 0.0019, P twoÀtailed ¼ 0.5262, 3000 permutations). Likewise, there was no evidence for inbreeding within individuals neither relative to the total sample nor relative to subgroups (F IT ¼ 0.0063, P twoÀtailed ¼ 0.5295, F IS ¼ 0.0031, P twoÀtailed ¼ 0.7241, 3000 permutations, when cases and controls are considered as two subpopulations). There is no sign of genetic differentiation among the different subsamples, and cases and controls are assumed to be part of the same panmictic population and share the same genetic history. Owing to the conservative way P 1 and P 2 are calculated, they may exceed a value of one when the observed value of the haplotype of interest is small. Bold values refer to chromosomal regions, markers, alleles and haplotypes.
Discussion
In contrast to pedigree-based genome-wide scans, we applied a LD-based approach, using singletons, to map susceptibility genes of autism. The interpretation of our study therefore expands to include all affected autistic individuals and not only familial cases. The present study revealed association for some of the regions previously identified as potentially containing candidate genes for autism. The most significant finding was at marker D3S3594 located 32.36 cM from pter. Shao et al. 41 found LOD scores up to 2.02 for the markers D3S3680 and D3S1259 in the region at 36 cM. At approximately 25 cM McCauley et al. 42 found a nonparametric allelesharing LOD score of 2.22 for marker D3S3691. Marker D3S1259 and D3S3691 appeared, however, not to be associated with autism in our study. Linkage analyses of complex disorders often suggest relatively large chromosome regions of interest, 43 which implies that cautiousness should be taken when comparing with results from more fine-scaled LD-based approaches like the present study. Chromosome 15q11-13 has been suggested to contain a susceptibility gene for autism based on several reports of chromosome abnormalities.
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More distally, at 51.21 cM, we found association with marker D15S198 and for the two-marker segment D15S198-D15S643, and Shao et al. 41 identified a region from 43.5 to 62.4 cM. On chromosome 6q marker D6S1652 (at 92.85 cM) appeared to be associated with autism and related PDDs. The same region was identified by Buxbaum et al. 44 in a sample of autism-affected relative pairs with more severe obsessive-compulsive (OC) behavior with LOD scores from 1.36 to 2.61. Our sample was, however, not characterized by OC behavior according to the categories defined to be OC behavior by Buxbaum et al. 44 On 18q, we found increased occurrence of a specific haplotype among cases at the 62.29-68.3 cM region spanning markers D18S536 and D18S970, and nearly the same region was identified by Philippe et al. 45 We also found significantly increased occurrence of alleles and haplotypes among cases on 5q, 12q, and 14q, but no clear evidence of involvement of these regions in autism has previously been indicated.
On chromosome 2, 16, and 17 we found association with autism and related PDDs, but no single allele or haplotype supported this. Chromosome 16p has been hypothesized to contain a susceptibility gene for autism based on genome-wide scans, association studies, 6, 42, [45] [46] [47] and reports of chromosome abnormalities. 45, [48] [49] [50] [51] Association between autism and tuberous sclerosis has been established, 52 and the gene for tuberous sclerosis 2 (TSC2) located in this region 53 has been found to be associated with autism. 54 Our data also provide further evidence for a susceptibility gene of autism and related disorders on 2q at 176 cM. This region has previously been identified as a candidate region for autism based on genome-wide linkage analysis 6, 7, 55 although other studies point more distally in the 210 cM region. 41, 45 As suggested by several genome-wide scans, 9 we found some support for the localization of a susceptibility gene for autism on 7q (121-129 cM) in the follow-up scan for different lengths of segments for all three data sets (consisting of seven, nine, and all 12 cases) with CLUMP P-values ranging from 0.0016 to 0.0159.
Based on the size of the Faroese population (45 000 inhabitants) and a prevalence of autism of 0.1-0.15%, we would expect to be able to find more than 40 cases. Our random sample of cases included males only, and the ascertainment method may thus be biased. The lack of female cases could be due to different clinical presentation 56 or that autism is under-recognized in Faroese females for cultural reasons, or due to early environmental influences. 57 Alternatively, the malefemale ratio could be a chance finding owing to the limited number of cases included.
Although the results for the subsamples differed only slightly from the analyses of the total sample, not all cases may be true cases of autism, in particular the three cases with severe mental retardation. We used ADI and ADOS, but it is generally accepted that ADI should not be applied to individuals with a mental age less than 18 months due to the difficulty in distinguishing autism-specific deficits from the general absence of directed behaviors in individuals with developmental levels less than 2 years of age. 58 De Bildt et al., 59 however, reported that ADI, and in particular ADOS, made satisfactory classifications of both childhood autism and PDD, compared to a clinical DSM-IV classification. 28 We therefore assume the cases to be diagnosed correctly, although the inclusion of non-PDD cases cannot be completely ruled out.
Care is required when generalizing from findings in isolated populations to outbred populations. Newman et al. 60 found similar frequencies of common alleles in both outbred and isolated populations, and it is likely that many of the common diseaseassociated variants detected in isolated populations will appear also to be associated with the disease in outbred populations. The advantages of using founder populations in mapping genes for complex disorders have been the subject of much debate, 61, 62 but they are considered to be very useful for several reasons. First of all, within the isolated population fewer susceptibility alleles are likely to exist, each perhaps with a relatively larger effect at population level, since random genetic drift during a founder event and past population bottlenecks may have eliminated some of Table 2 Results from STRUCTURE analysis
the susceptibility alleles present in the source population, thereby reducing the allele and locus heterogeneity at the population level. Furthermore, background LD may due to random genetic drift extend over greater genetic distances in isolated populations, thereby reducing the sample size and the number of markers needed to identify specific genes. 63, 64 In addition, isolated populations may be more suitable for association mapping because of the more homogeneous environmental background. 63, 65 Conflicting evidence has, however, been reported regarding the actual degree of homogeneity of isolated populations. 64 A previous study on the Faroese population 25 indicated extensive LD among the 15 markers surveyed. Furthermore, the allelic diversity was smaller, although nonsignificant in the Faroese population compared to outbred populations. Despite lack of evidence for a strong population bottleneck on the Faroe Islands, the population is considered suitable for LD mapping of complex diseases. 25 To avoid bias due to population stratification, it is essential that cases and controls are subsamples of the same panmictic population and share a similar genetic history. Based on Wright's F ST and modelbased clustering analyses, this essential assumption seems valid for our sample of cases and controls. We found no convincing genetic evidence indicating that cases are actually more related to each other than they are to controls. Although a few individual pair of cases might be more related than the average, the findings indicate that the control sample somehow falls into the same genealogy as shown for cases, and the bias inflation of P-values introduced is limited. STRUCTURE using most of the information from the current data set available including partial phase information should potentially be able to identify clusters if cases are indeed more related to each other than they are to controls, which was not the case. Considering the history of the Faroese population, it is not surprisingly that controls seem to fall into the same genealogy as cases (Figure 1 ). Going 12 generations back in time, each individual has 2 12 ¼ 4096 ancestors. The Faroese population size 12 generations ago was somewhere around 4000 individuals. In total, 56 randomly chosen contemporary individuals therefore probably have several common ancestors living 12 generations ago.
The power of this study is currently unknown, and exact power estimation is complicated by the complexity of the genealogical structure, the unknown mode of disease inheritance, and the unknown number of genes involved in disease etiology as well as the magnitude of their effects. The use of microsatellite markers increases the informativeness compared to SNPs, but decreases power due to the highly polymorphic nature of microsatellites. This problem created by the marker type used is partially counteracted using CLUMP. 38 CLUMP evaluates all alleles or haplotypes in one test, and low P-values may be caused by differences in frequencies of more than one allele or haplotype. The significant P-values of Fisher's exact tests (Pp0.01) testing for frequency differences of a specific allele or haplotype are generally lower than the P-values obtained by CLUMP indicating that the deviation in frequency between cases and controls may be caused by a single allele or haplotype. No correction for type I error was made, despite the large number of tests performed, but a relatively low level of significance (Pp0.01) was chosen. Since many of the markers are in close proximity and in extensive LD, 25 the association tests performed cannot be considered independent, and the standard procedure for correction for type I error will therefore be too conservative. There is no generally accepted method to make the appropriate correction, although simulation-based statistics are being explored. 66 The significance of the results obtained in this study is supported by using a combined approach including an assumption-free test as implemented in CLUMP, Fisher's exact test, and IBD 0 probability calculations.
The number of larger segments found to be associated with autism was rather limited. This could in part be explained by the small sample size that decreases the chance of detecting larger segments. Furthermore, the average size of a region among related cases inherited IBD from a common ancestor is directly proportional to the number of generations that has passed since the common ancestor. The number of generations to a common ancestor for a pair of cases ranges from three to 12, with an average of 7.2 generations for a single pair of cases. Based on the number of generations to a common ancestor for each pair of cases in the genealogy (Figure 1 ), a rough estimate of the expected size of a shared IBD segment among a pair of cases is 14.96 cM (see Wright et al. 67 and Ober and Cox 68 for details). Assuming that all 12 individuals had inherited a single copy of a susceptibility locus from a common ancestor, the expected size of the surrounding segment shared among all 12 cases would be further diminished, suggesting that the size of the segment shared between two to 12 cases would be within 1.25-14.96 cM depending on the number of cases actually sharing the susceptibility allele. The above calculations, however, are rough estimates and based on the assumption of recombination homogeneity throughout the genome which is unlikely. 69 In addition, the markers used in the current study are not evenly distributed throughout the genome, and we may have missed some of the segments shared among cases.
Our study does not provide any support for a single susceptibility locus significantly increasing the risk of developing autism on the Faroe Islands. Instead several additional genetic loci, each with a small effect, most likely contribute to the risk of autism. This study may not, however, have enough power to detect disease genes with a weak effect. Despite the limited number of cases, it was possible to detect some candidate regions of autism. The replication of findings on chromosome 2, 3, 6, 15, 16, and 18 across different study populations is promising with respect to the identification of susceptibility genes of autism in the future. The inclusion of additional cases and controls, and further analyses with more densely distributed markers in candidate regions, is relevant in order to further investigate the significance of the present findings, and to eventually localize susceptibility genes of autism.
